While ADAM12 knockdown did not alter intrinsic radiosensitivity in cell culture models, in vivo experiments using ADAM12-deficient CT26 cells revealed significantly delayed tumour growth and improved survival following irradiation, implicating ADAM12 in modulating the tumour microenvironment (TME) rather than direct cell-autonomous effects. Here, ADAM12 is linked to neoplasm.